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Abstract
Saccharomyces cerevisiae strains of clinical and nonclinical origin were compared by
pulse ﬁeld gel electrophoresis. Complete separation between strains of clinical origin
and food strains by their chromosome length polymorphism was not obtained even
though there wasa tendency for theclinical andfoodstrains to cluster separately. All
theinvestigatedstrains, except forone food strain, were able togrow at temperatures
Z371Cb u tn o ta t4 2 1C. Great strain variations were observed in pseudohyphal
growth and invasiveness, but the characters were not linked to strains of clinical
origin. The adhesion capacities of the yeast strains to a human intestinal epithelial
cell line (Caco-2) in response to different nutritional availabilities were determined,
as were the effects of the strains on the transepithelial electrical resistance (TER)
across polarized monolayers of Caco-2 cells. The yeast strains displayed very low
adhesion capacities to Caco-2 cells (0.6–6.2%), and no signiﬁcant difference was
observed between the strains of clinical and nonclinical origin. Both S. cerevisiae
strains of clinical and non-clinical origin increased the TER of polarized monolayers
of Caco-2 cells. Based on the results obtained in this study, no speciﬁc virulence
factor was found that clearly separated the strains of clinical origin from the strains
of nonclinical origin. On the contrary, all investigated strains of S. cerevisiae were
found to strengthen the epithelial barrier function.
Introduction
An increasing number of reports about the involvement of
Saccharomyces cerevisiae in superﬁcial and life-threatening
systemic diseases (Hennequin et al., 2000; Perapoch et al.,
2000; Lherm et al., 2002; Wheeler et al., 2003; Munoz et al.,
2005; de Llanos et al., 2006a,b) have led to the replacement
of this organism from the group of generally recognized as
safe (GRAS) to a group of opportunistic pathogens of
low virulence (de Hoog, 1996). Also, increasing evidence
of infections by probiotic strains of Saccharomyces cerevisiae
var. boulardii (van der Aa K¨ uhle & Jespersen, 2003) has been
reported (Perapoch et al., 2000; Cassone et al., 2003;
Riquelme et al., 2003; de Llanos et al., 2006b). Clinical cases
are caused by oral administration, blood infections or other
ways of exogenous inoculation. The patients infected are in
most cases premature children, elderly people or patients
suffering from immunosuppression due to AIDS, treatment
with immunosuppressive agents, etc. However, it is still
unclear whether some S. cerevisiae strains are more likely
to cause infections than others (Nyirjesy et al., 1995;
Perapoch et al., 2000; Lherm et al., 2002; Cassone et al.,
2003; Riquelme et al., 2003).
Many epidemiological characterizations of S. cerevisiae
isolated from clinical specimens have been performed
(Zerva et al., 1996; Clemons et al., 1997; McCullough et al.,
1998; Posteraro et al., 1999), but the strains are often not
characterized by appropriate typing techniques. Determina-
tion of chromosome length polymorphism (CLP) is well
recognized as a useful method for typing and characteriza-
tion of strains of S. cerevisiae from different types of foods
(Jespersen et al., 1999, 2000, 2005; van der Aa K¨ uhle et al.,
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and characterization of starter cultures and contaminants.
However, the method has not been used for characterization
of S. cerevisiae strains of clinical origin.
Some of the reported key elements of virulence are the
ability to grow at high temperatures (39–421) and the ability
of the yeast species in vitro to perform a dimorphic switch
between unicellular growth and pseudohyphal growth,
which is generally considered an important adaptive response
to environmental stress conditions such as e.g. nutritional
deprivation (Lorenz et al., 2000; Gagiano et al., 2002; Palecek
et al., 2002; Casalone et al., 2005). Invasive growth on solid
agar has also been reported as a virulent trait (McCusker
et al., 1994a,b; Palecek et al., 2002; Casalone et al., 2005).
Upon oral administration, adhesion to mammalian
epithelial cells is likely to be crucial to ensure maintenance
of the yeast in the human host and a prerequisite for
invasiveness and clinical symptoms (Kleinschmidt et al.,
2005; Kumamoto & Vinces, 2005). Previously, mammalian
epithelial cells have been used as in vitro models for the
adhesion of e.g. probiotic bacteria and yeasts to the gastro-
intestinal (GI) tract (van der AaK¨ uhle et al., 2005; Klingberg
et al., 2005a) and to determine the permeability of the
epithelium by measurements of the transepithelial electrical
resistance (TER) (Klingberg et al., 2005b). The addition of
various pathogenic bacteria has been shown to increase the
permeability of the epithelium, leading to deterioration of
the epithelial barrier function (Nusrat et al., 2001; Tafazoli
etal., 2003), whereas probiotics have been shown to decrease
the permeability of the epithelium (Resta-Lenert & Barrett,
2003; Klingberg et al., 2005b). Measurements of the TER of
polarized monolayers of epithelial cells are therefore seen as
a useful method of providing information about potential
virulence or the probiotic effect of microorganisms upon
oral administration.
As S. cerevisiae is widely present in many foods and
beverages, it has been the aim of the present study to
investigate in in vitro models whether strains of S. cerevisiae
isolated from clinical specimens could be separated from
strains of S. cerevisiae originating from food or being used as
probiotics. The strains were compared by their CLP and
previously reported virulence traits. Yeast adhesion and
inﬂuence on the TER of the epithelium were evaluated using
a human intestinal epithelial cell line (Caco-2).
Materials and methods
Yeast strains and growth media
The origins of the clinical and nonclinical strains of
S. cerevisiae used in the present study are listed in Table 1.
Strains denoted SSI are isolated from clinical specimens and
kindly provided by Statens Serum Institute, Copenhagen,
Table 1. Strains of Saccharomyces cerevisiae included in the present
study
Name Origin Supplier
Strains of clinical origin
SSI1 Toe Statens Serum Institute,
Copenhagen
Denmark
SSI2 Adrenal gland
SSI3 Blood
SSI4 (RH 7806)
SSI5 (Hvidovre112)
SSI6 Vagina
SSI7 Vagina
SSI8 Vagina
SSI9 Vagina
YJM128 (CBS 7833)
w Lungs Centraalbureau voor
Schimmelcultures
(CBS),
Utrecht, the
Netherlands
YJM222 (CBS 7834)
w Man
YJM273 (CBS 7835)
w Peritoneal ﬂuid
YJM308 (CBS 7836)
w Paracentesis ﬂuid
YJM309 (CBS 7837)
w Blood
YJM310 (CBS 7838)
w Man
YJM311 (CBS 7839)
w Bile tub
YJM312 (CBS 7840)
w Ascites ﬂuid
Probiotic strains
7103
z,‰ Ultra-Levure, batch 7103
(S. cerevisiae var. boulardii)
Laboratoires Biocodex,
Montrouge, France
259
z,‰ Precosa
s, batch 259
(S. cerevisiae var. boulardii)
Logic aps., Lynge,
Denmark
LSB
z,‰ Levucell
s SB, feed
supplement
(S. cerevisiae var. boulardii)
Euro Tier,
Niederzissen,
Germany
Food strains
56
‰,z Danish blue veined cheese The Faculty of Life
Sciences,
Department of Food
Science, Copenhagen,
Denmark
D7
‰ Gorgonzola, Italy
A6
‰,k Sorghum beer, Ghana
A18
‰,k Sorghum beer, Ghana
C1
‰,k Sorghum beer,
Burkina Faso
KVL012
‰, Brewing ale yeast
Laboratory haploid strain
S288C (CBS 8803) CBS, Utrecht,
the Netherlands
Strains of clinical origin were identiﬁed by use of API ID 32 C kit (BioMerieux
SA, Marcy L’Etoile, France) according to the manufacturer’s instructions. All
strains were identiﬁed as Saccharomyces cerevisiae.
wThe strains were purchased from the CBS collection. The names used in this
paper are in coherence with the names used by McCusker et al. (1994a,b),
Byron et al. (1995) and Clemons et al. (1997).
zSaccharomyces cerevisiae var. boulardii (van der Aa K¨ uhle & Jespersen, 2003)
‰van der Aa K¨ uhle et al. (2005).
zHansen & Jakobsen (2001).
kvan der Aa K¨ uhle et al. (2001).
Jespersen et al. (1999).
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632 T.D. Klingberg et al.Denmark, whereas strains denoted YJM were obtained from
Centraalbureau voor Schimmelcultures (CBS), Utrecht,
the Netherlands. These strains were included as they have
previously been shown to display different degrees of
virulence in CD-1 mice (McCusker et al., 1994a,b). The
probiotic strains (7103, 259 and LSB) were purchased from
different commercial suppliers (see Table 1), and strains
isolated from food (56, D7, A6, A18, C1, KVL012) were
obtained from the yeast collection at the Department of
Food Science, The University of Copenhagen, Frederiksberg,
Denmark. The haploid strain S288C (CBS8803) was
obtained from CBS and included as reference. All strains
were maintained at  801C in 20% (v/v) glycerol (Merck,
Darmstadt, Germany). Strains were propagated in YPD
broth [1% (w/v) glucose (Merck), 1% (w/v) Bacto Peptone
(Difco, Detroit, MI), 0.5% (w/v) yeast extract (Difco), pH
5.6] for 24h at 301C.
For induction of pseudohyphae, synthetic low-nitrogen
medium [SLAD; 2% (w/v) glucose (Merck), 2% (w/v)
Bacto Peptone (Difco), 0.65% (w/v) yeast nitrogen base
without amino acids and ammonium sulphate (Difco) and
50mmolL
 1 ammonium sulphate (Merck)] (Gimeno et al.,
1992) and synthetic complete low dextrose medium [SCLD;
0.17% (w/v) yeast nitrogen base (Difco), 40mmolL
 1
ammonium sulphate (Merck), 0.1% (w/v) glucose (Merck)]
(Gagiano et al., 2003) were used. For preparation of agar
plates, 2% (w/v) of agar (Difco) was added.
CLP and cluster analysis
Yeast cultures were grown in YPG broth [10gL
 1 yeast
extract (Difco), 20gL
 1 Bacto Peptone (Difco) and 40gL
 1
glucose (Merck), pH 5.6] at 251C for 48h, and successively
recultivated for 24h. Spheroplasts and agar blocks were
prepared as described previously by Hayford & Jespersen
(1999). The gel was run at 101C for 40h (90s for 14h, 105s
for 12h and 120s for 14h) at 100–120mA and 160V
(CHEF-DR
sIII System, Bio-Rad Laboratories) in TBE
buffer [45mmolL
 1 Tris-base (Sigma), 44mmolL
 1 boric
acid (Sigma) and 1mmolL
 1 EDTA]. Yeast DNA marker
(Pharmacia) was used for determination of chromosome
size. The gel was stained with 1mgL
 1 ethidium bromide
(Sigma) for 30min, washed in Milli-Q water for 5min,
visualized with a UV transilluminator (Pharmacia) and
photographed with a land camera (Polaroid MPE,
Cambridge, MA). The pulse-ﬁeld gel electrophoresis
(PFGE) analyses of the strains were repeated twice in two
separate experiments. The software BIONUMERICS 2.50
(Applied Maths, Kortrijk, Belgium) was used for normal-
ization and processing of the yeast chromosome profiles.
Cluster analysis was based on the Dice coefficient and the
unweighted pair group algorithm with arithmetic averages
(UPGMA).
Growth temperature assays
YPD broth (10mL) was inoculated with a single yeast
colony, grown on YPD agar for 48h at 301C. Growth was
determined by visual examination following 3, 7, 14 and 28
days of incubation at 35, 37, 39 and 421C (Yarrow, 1998).
The experiments were conducted twice.
Cell elongation measurements
Broth or agar of YPD, SLAD or SCLD were inoculated with
overnight culture (24h at 301C) and incubated for 24h
(YPD broth), 48h (SLAD and SCLD broth) or 4 days (YPD,
SLAD and SCLD agar) at 301C. Cells from the edges of the
colonies were suspended in Milli-Q water before the cell
elongation measurements. The cells were examined using
a Zeiss Axiovert 135TV (Carl Zeiss) microscope equipped
with a  63 C-apochromat water-immersion objective.
Images werecaptured by a Coolsnap
TMfx (RS Photometrics)
camera. METAMORPH (Universal Imaging Corp.) image-acqui-
sition software was used to manually obtain major and
minor axis lengths of 50cells of each strain. Cell elongation
was calculated as a mean value of ratios between major and
minor axis length. The experiment was conducted twice.
Significance was determined using the two-tailed Student’s
t-test and P values o0.05 were considered significant.
Pseudohyphal growth
Strains were propagated overnight in YPD at 301C and
streaked onto YPD, SLAD and SCLD agar. After 1 week of
incubation at 301C, colonies were examined for pseudohyphal
growth by bright-ﬁeld microscopy using a Zeiss Axioscop
50 microscope (Carl Zeiss, Germany) equipped with a  100
objective. Images were captured by a CoolSnap
TMcf camera
(RS Photometrics) (Lo & Dranginis, 1998). The experiment
was conducted twice.
Invasive growth assay
Strains were propagated in YPD broth overnight at 301C,
streaked onto agar of YPD, SLAD or SCLD and incubated
for 3 days at 301C followed by 2 days at room temperature.
Invasive cells were detected after washing the cells off the
agar with a gentle stream of Milli-Q water and a gloved
ﬁnger (Lo & Dranginis, 1998). The agar plates were scanned
(Powerlook 1120, UMAX Technologies Inc.) before and after
washing for comparison. The experiment was conducted
twice with separate propagations of the yeast cultures.
Growth and maintenance of mammalian
cell cultures
The human colon adenocarcinoma cell line Caco-2 was
purchased from the Deutche Sammlung von Mikroorganism
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633 Saccharomyces cerevisiae strains of clinical and nonclinical originund Zellkulturen (DSMZ, Braunschweig, Germany) and
grown in minimum essential medium (Earle’s salt, 25mM
HEPES and GlutaMAX
TM, Invitrogen, Gibco, Rockville,
MD) supplemented with 16.5% (v/v) foetal bovine serum
(FBS, Cambrex Bio Science, Verviers, Belgium), 1% (v/v)
nonessential amino acids (Invitrogen, Gibco) and 50mgmL
 1
gentamicin (Invitrogen, Gibco). The cells were routinely
grown in 150cm
2 culture ﬂasks (TPP, Trasadingen, Switzer-
land) at 371C in a humidiﬁed atmosphere of 5% CO2 and
95% air until a conﬂuent monolayer was obtained. Culture
medium was changed every second day.
Adhesion capacity to mammalian cells
The adhesion capacity of selected S. cerevisiae strains of
clinical and nonclinical origin to Caco-2 cells was investi-
gated in vitro with or without previous nitrogen starvation.
The strains were selected to represent strains of both clinical
and nonclinical origin. D7 is a food strain that forms
extensive pseudohyphal growth on both YPD and SLAD
solid media and further clustered together with the strains
of clinical origin when analysed by the PFGE techniques,
7103 is a probiotic strain, SSI4 and SSI6 are strains from
blood and vagina respectively, and YJM 222 (CBS 7834) and
YJM 311 (CBS 7839) are strains of clinical origin having
variousdegreesofpseudohyphalgrowth(Fig.2).Additionally,
YJM 222 and YJM 311 have previously been reported to
have different degrees of virulence (McCusker et al., 1994a).
Monolayers of Caco-2cellswere seeded at aconcentration of
2 10
5cellsmL
 1 and dispensed into each 400mm
2 well of
a 12-well tissue culture plate (Nunc, Roskilde, Denmark)
and incubated at 371C in a humidiﬁed atmosphere of 5%
CO2 and 95% air until monolayers were developed (4 days).
The yeast strains were grown overnight at 301C in YPD or
SLAD broth or for 1 week on YPD or SLAD agar and
resuspended in Caco-2 growth medium to a ﬁnal concen-
tration of 10
7CFUmL
 1. The yeast suspension (1mL) was
added to each well of the tissue culture plate containing
monolayers of Caco-2 cells. After 1h of incubation the
monolayers were washed three times with Caco-2 cell
growth medium in order to remove nonadherent yeast. The
Caco-2 cells were lysed by the addition of 0.1% (v/v) Triton-
X100 (Merck), and the number of viable adherent yeast was
determined by plating serial dilutions onto YPD agar. CFUs
were enumerated after incubation for 48h at 301C, and the
adhesion capacity is described as the percentage of yeast
adhered to Caco-2 cells compared with the total number of
yeast added. Each adhesion assay was conducted twice (two
different passages) with triplicate determinations.
Effect of S. cerevisiae strains on TER
To obtain polarized monolayers, Caco-2 cells wereseeded on
Transwell
s ﬁlter inserts (0.4mm pore size, 12-mm id,
Corning Incorporated, Corning, NY) placed into 12-well
plates (diameter: 22.1mm; Corning Incorporated) at a
density of 1 10
5cellscm
 2. Avolume of 500mL cell growth
medium was added to the inner chamber (apical compart-
ment) and 1500mL to the outer chamber (basolateral
compartment). Functional polarity was developed when
electrical resistance between the apical and basolateral sur-
face of the monolayers was 4450Ocm
 2. The same strains
were included as described in the adhesion study. Strains
grown overnight at 301C in YPD were resuspended in Caco-
2 cell growth medium (10
7cellsmL
 1). The yeast suspension
(500mL) was added to the apical compartment and incu-
bated at 371C in a humidiﬁed atmosphere of 5% CO2 and
95% air. The effects of the yeast strains on cell polarity were
evaluated by measurement of the TER using the Millicell-
ERS Electrical Resistance System (Millipore, Bedford, MA).
The net value of the TER (Ocm
 2) was corrected for
background resistance by subtracting the contribution of
the cell free ﬁlter and the medium (110Ocm
 2). The TER
was measured before the addition of the yeast (t=0) and
then at various time intervals (1, 2, 3, 4, 5, 6, 7, 8 and 24h).
The TER of monolayers with Caco-2 cell culture media
without added yeast represented the control for each experi-
ment. Each assay was conducted twice (two different pas-
sages) with triplicate determinations.
Results
CLP
All investigated strains had chromosome proﬁles typical of
S. cerevisiae with chromosomes ranging in size from 200 to
1900kbp (results not shown). CLP was observed among
the strains, and the technique was able to separate nearly all
strains. The cluster analysis is seen in Fig. 1. Five (i.e. 56,
KVL012, A6, A18 and C1) of the six food strains were found
to cluster together and could be separated from the remain-
ing strains at a level of 36% similarity. The remaining food
strain (D7) was found to cluster within the strains of clinical
origin. Two of the probiotic strains of S. cerevisiae var.
boulardii (LSB and 259) had identical proﬁles and clustered
together with the third probiotic strain (7103) at a similarity
of more than 90%. The cluster containing the probiotic
strains clustered within the larger cluster of clinical strains.
Also, two of the clinical strains (SSI7 and SSI8; both vaginal
isolates) were quite alike and clustered together at a similarity
of c. 90%. The ﬁve food strains (i.e. 56, KVL012, A6, A18 and
C1) that clustered together were separated from the remain-
ingstrainsduetoalowerbandsize,especiallyofchromosome
XVIandXIII(c.915–945kb)andchromosomeIII(c.375kb).
For the haploid strain S288C, only 15 chromosomal bands
were observed due to lack of separation between chromo-
some VII (c. 1120kb) and chromosome XV (c.1 1 0 0k b ) .
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634 T.D. Klingberg et al.Growth at elevated temperatures
The ability to growat elevated temperatures was investigated
in liquid media (results not shown). All investigated strains,
except KVL012, were able to grow at both 35 and 371C.
KVL012 is a domesticated ale yeast strain that has been used
in the brewing industry for decades, where the temperature
hardly exceeds 251C, and it is therefore not surprising
that it does not grow at 351C. At 391C, all strains, except
SSI2 and KVL012, were able to grow within 7 days. After
4 weeks of incubation at 391C, extensive growth was
observed for SSI2. None of the investigated strains were able
to grow in liquid medium at 421C, not even after 4 weeks
of incubation.
Cell elongation
The morphological differences of cells grown in liquid rich
YPD medium and both in liquid and on solid low-nitrogen
(SLAD) and low-carbon (SCLD) media were investigated
(results not shown). Signiﬁcantly elongated cells were found
on solid SLAD compared with solid SCLD (P=3 10
 5).
Similarly, signiﬁcant elongated cells were observed when
solid SLAD was compared with liquid SLAD (P=0.003).
Increased elongation was especially observed for four of the
strains of clinical origin (SSI5, SSI7, YJM222 and YJM311)
and for one of the food strains (D7). Otherwise no sig-
niﬁcant differences were observed among the media and the
strains included.
Pseudohyphal growth and invasiveness
Pseudohyphal growth was examined (Fig. 2 and Table 2).
Great variations were observed among both the strains and
the media used. On YPD solid medium 12% of the strains
of clinical origin, none of the probiotic strains and 33% of
the food strains showed pseudohyphal growth after 7 days of
incubation. In general, incubation on solid SLAD (low-
nitrogen medium) caused a signiﬁcant increase in pseudo-
hyphal growth. On this medium, 65% of the strains of
clinical origin, 100% of the probiotic strains and 83% of the
food strains showed pseudohyphal growth. On the contrary,
none of the investigated strains had the ability to form
pseudohyphal growth on solid SCLD (low-carbon med-
ium). The ability to form pseudohyphal growth was not
4
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Fig. 1. Dendrogram showing the clustering of 27 strains of Saccharomyces cerevisiae (three of the strains are S. cerevisiae var. boulardii, i.e. LSB, 259
and 7103) based on their CLP as determined by PFGE and evaluated using the Dice coefﬁcient and the unweighted pair group algorithm with arithmetic
averages (UPMGA).
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635 Saccharomyces cerevisiae strains of clinical and nonclinical originalways associated with cell elongation (results not shown).
As expected, the haploid strain S288C was not able to form
pseudohyphal growth on any of the three media. The
invasiveness of the strains at 301C on solid YPD, SLAD and
SCLD media is additionally shown in Table 2. Variations in
the invasiveness were observed among both the strains and
the media used. None of the three probiotic strains showed
invasiveness on any of the three media. For solid YPD (rich
medium), 35% of the strains of clinical origin, none of the
probiotic strains and 50% of the food strains showed
invasiveness. On the solid SLAD (low-nitrogen medium),
65% of the strains of clinical origin, none of the probiotic
strains and 100% of the food strains showed invasiveness.
On the solid SCLD (low-carbon medium), invasiveness was
Fig. 2. Colony morphology of Saccharomyces cerevisiae strains grown on solid rich-media (YPD), low-nitrogen media (SLAD) or low-carbohydrate
media (SCLD).
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636 T.D. Klingberg et al.seen for 24% of the strains of clinical origin, none of the
probiotic strains and 67% of the food strains. Some strains
did show a high degree of invasiveness on all media. This
accounts for the clinical strains YJM128, YJM273, YJM309
and YJM311 as well as for the food strains D7 and 56. Both
of the high invasive food strains (D7 and 56) are used in
solid-state fermentation (blue veined cheeses), where their
ability to invade the substrate is of importance for their
establishment. In conclusion, pseudohyphal growth and
invasiveness were not tightly correlated, and pseudohyphal
formation appeared not always to be a prerequisite for
invasiveness. No differences were observed between strains
of clinical and nonclinical origin.
Adhesion to mammalian cell cultures
As seen in Fig. 3, all the investigated strains adhered poorly
(0.6–6.2%) after growth in liquid YPD or SLAD, and no
signiﬁcant difference was observed between the two media.
Furthermore, no signiﬁcant difference in the adhesion
capacity was observed between strains of clinical and non-
clinical origin. For cells of S. cerevisiae D7, pregrowth on
solid YPD or solid SLAD did not inﬂuence the adhesion
capacity of the cells. The adhesion capacity to Caco-2 cells
was 2.3 1.2% after growth in liquid YPD compared with
2.5 0.4% after growth on solid YPD. Similarly, an adhe-
sion capacity of 1.7 1.4% was observed for D7 after
growth in liquid SLAD compared with 2.7 1.3% after
growth on solid SLAD. Based on these results, the adhesion
capacity of the yeast to human intestinal cells appears not to
be inﬂuenced by the investigated pregrowth conditions
(substrate consistency and nitrogen availability).
TER
Both strains of clinical (SSI4, SSI6, YJM222 and YJM311)
and nonclinical (D7 and 7103) origin increased the TER of
polarized Caco-2 monolayers from c. 500 to c. 600O after
1h of incubation (Fig. 4). No signiﬁcant changes were
observed for the next 7h. After 24h of incubation, an
increase in TER to c. 700O was observed for ﬁve of the
strains (D7, 7103, SSI6, YJM222 and YJM311), whereas the
increase for SSI4 was slightly lower. The TER of Caco-2
monolayers without added yeast varied slightly around
c.5 0 0O during the incubation period. Based on these results,
S. cerevisiae strains were in general found to strengthen the
epithelial barrier function, and no differences were observed
between strains of clinical and nonclinical origin.
Table 2. Pseudohyphal formation and invasiveness by Saccharomyces
cerevisiae strains when grown on solid YPD, SLAD or SCLD media at
301C
Strain/Condition
YPD SLAD SCLD
PH IG PH IG PH IG
Strains of clinical origin
SSI1         
SSI2         
SSI3     1   
SSI4    11 1   
SSI5     1   
SSI6         
SSI7         
SSI8    1     
SSI9    11 1   
YJM128   11 1 11   111
YJM222    1     
YJM273   11 1 11   11
YJM308 1 11 1 111   
YJM309   11 1 11   111
YJM310   1 1 111   
YJM311 1 111 1 11   111
YJM312    11   
Probiotic strains
7103    1     
259    1     
LSB    1     
Food strains
D7 11 1 11 1   11
56 1 111 1 111   111
C1    11 1   
A18    11 1   111
A6    11   11
KVL012   1   11   
Laboratory haploid strain
S288C         
The strains were grown on solid rich (YPD), low-nitrogen (SLAD) or
low-carbohydrate (SCLD) media.
The presence of pseudohyphal growth (PH) is denoted: 1. For invasive
growth (IG) the patterns are divided into four groups according to the
intensity:  , no invasive growth; 1, moderate invasive growth; 11,
intermediate invasive growth; 111, enhanced invasive growth.
0
5
10
15
D7 7103 SSI4 SSI6 YJM222 YJM311
A
d
h
e
s
i
o
n
 
c
a
p
a
c
i
t
y
 
(
%
) YPD
SLAD
Fig. 3. The adhesion capacity of Saccharomyces cerevisiae strains pro-
pagated in rich media (YPD) or low-nitrogen media (SLAD) to Caco-2
cells expressed as the percentage of adhered yeast cells (CFUmL
 1)
compared with added yeast cells (1 10
7CFUmL
 1). Each adhesion
assay was conducted twice (two different passages) with triplicate
determinations. The error bars indicate the SDs.
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637 Saccharomyces cerevisiae strains of clinical and nonclinical originDiscussion
All chromosome proﬁles obtained in the present study were
found to be typical of S. cerevisiae, which conﬁrms the
identiﬁcation of the strains. Besides, all strains of clinical
origin were clearly separated by the PFGE technique, and
determination of CLP can therefore be recommended as a
useful tool for proﬁling and tracing clinical strains of
S. cerevisiae. A complete separation between strains of clinical
origin and food strains was not obtained even though there
was a tendency for the clinical and food strains to cluster
separately. The probiotic strains clustered together within
the strains of clinical origin. These results are comparable to
results reported in other studies using typing techniques
such as restriction fragment length polymorphism of chro-
mosomal DNA, restriction analysis of digested mtDNA and
PCR ampliﬁcation of delta sequences (McCullough et al.,
1998; de Llanos et al., 2004, 2006b).
Growth at 371C is, according to Vaughan-Martini &
Martini (1998), a variable characteristic of S. cerevisiae.I n
this study all strains of clinical origin as well as the majority
of the food strains were able to grow at 391C when grown in
liquid media. None of the investigated strains in this study
were able to grow at 421C. The present study does show
that growth at 421C is not a prerequisite for host persistence
as reported earlier (McCusker et al., 1994a,b) for growth on
solid media.
Both pseudohyphal growth and invasive growth were
highly strain speciﬁc even though not always linked. Both
characteristics were increased when grown on SLAD. This
is in agreement with several other authors (Lambrechts
et al., 1996; Prinz et al., 2004; Casalone et al., 2005;
Kleinschmidt et al., 2005). The ratio of strains capable of
invading the SLAD agar was in the same order as reported
previously for wine and must strains by Casalone et al.
(2005), who also, as in the present study, found that a few of
the strains were able to invade the SLAD agar even though
pseudohyphal growth was not observed. The ratio of strains
capable of agar invasion was comparable for strains of
clinical and nonclinical origin, and penetration of solid
standardized laboratory media therefore does not appear
to be linked to the ability of the strains to cause human
infections. However, it cannot be excluded that factors
in the gastrointestinal tract may trigger pseudohyphal
growth and invasiveness as previously reported for Candida
albicans when exposed to an undeﬁned serum factor
(Feng et al., 1999).
Generally, no signiﬁcant difference in adhesion to mam-
malian epithelial cells was found between strains of clinical
and nonclinical origin. Compared with previous adhesion
studies, using a porcine intestinal cell line (van der Aa K¨ uhle
et al., 2005), the yeast strains adhered poorly to the human
intestinal cell line, indicating a weak ability to establish in
the human intestine. In the current study, we demonstrated
that the TER of polarized Caco-2 monolayers increased
following exposure to S. cerevisiae strains of both clinical
and nonclinical origin, thereby strengthening the epithelial
barrier function in a similar manner as seen previously
for probiotic bacteria (Czerucka et al., 2000; Resta-Lenert &
Barrett, 2003; Otte & Podolsky, 2004; Klingberg et al.,
2005b). These results indicate that the examined yeast
strains do not destabilize the epithelium when exposed to
a healthy intestine. In addition, these results are in line
with the fact that most infections of S. cerevisiae arereported
in immunocompromised people (Cassone et al., 2003;
Riquelme et al., 2003) with a disrupted barrier function
due to infections or inﬂammatory bowel diseases (Madsen
et al., 2001), consequently allowing access of luminal yeast
cells into the underlying tissue and bloodstream of the host.
In conclusion, it was not possible in the present study
to identify a speciﬁc virulent factor that could be used to
separate between S. cerevisiae strains of clinical and non-
clinical origin in any of the physiological tests or in the
in vitro mammalian cell model. In fact, all investigated strains
were capable of increasing the TER of polarized monolayers
of Caco-2 cells, indicating that these strains might have a
protective impact on healthy human GI tract functions.
These results imply that the examined yeast strains, even
though some of them are isolated from clinical specimens,
are not harmful when exposed orally to a healthy intestine.
Based on the present observations, the immunological status
of an exposed individual appears to be a much more
Fig. 4. TER of polarized Caco-2 monolayers exposed to Saccharomyces
cerevisiae of nonclinical origin [D7 (&) and 7103 (m)] or S. cerevisiae
strains of clinical origin [SSI4 (D), SSI6 (}), YJM222 (^), YJM311 (1)]
at a concentration of 1 10
7yeastmL
 1 or without yeast added (’)
(control). Each assay was conducted twice (two different passages) with
triplicate determinations. The error bars indicate the SD.
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638 T.D. Klingberg et al.signiﬁcant factor in the development of infections caused by
S. cerevisiae than the yeast strain characteristics.
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